Overexpression of CD85j in TNBC patients inhibits Cetuximab‐mediated NK‐cell ADCC but can be restored with CD85j functional blockade
Publisher: John Wiley & Sons Inc
E-ISSN: 1521-4141|45|5|1560-1569
ISSN: 0014-2980
Source: EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.5, 2015-05, pp. : 1560-1569
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract